Please Wait.....
Report
CRISPR Technology: Global Markets
Market Research Report I 2023-01-06 I 131 Pages I BCC Research
Description
Report Scope:
The current report provides detailed exposure to the CRISPR technology market. This report highlights the current and future market potential of CRISPR technology, along with a detailed analysis of the drivers, restraints, and challenges in the market. The report also covers market projections for 2027, as well as the competitive environment and regulatory scenario. The report details the market share of CRISPR technology on applications and end users. The market is segmented into Biotechnology & Pharmaceutical Companies, Academics & Government Research Institutes, and Contract Research Organizations (CROs) based on end users. The market is categorized as Drug Development, Agriculture, Diagnostics, Clinical therapy, and Others based on Application. The report includes the company profiles of the key players with detailed information about their business segments, financials, product portfolios, and recent developments. The report also discusses the impact of the COVID-19 pandemic on this market.
By geography, the market has been segregated into North America, Europe, Asia-Pacific, and the Rest of the world. The North American region includes countries such as the U.S. and Canada; Europe includes Germany, U.K., France, and the Rest of Europe; Asia-Pacific includes China, India, Japan, and the Rest of Asia-Pacific. For market estimates, data has been provided for 2019 as the historic year, 2021 as the base year, and forecast for 2027.
Report Includes:
- 17 data tables and 37 additional tables
- An up-to-date overview and analysis of the global market for CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) technology
- Analyses of the global market trends, with historic revenue data for 2019-2021, estimates for 2022, and projections of compound annual growth rates (CAGRs) through 2027
- Highlights of the market potential for CRISPR technology, industry growth drivers, and areas of focus to forecast this market into various segments and sub-segments
- Estimation of the actual market size and revenue forecast for the global CRISPR technology market in USD million terms, and corresponding market share analysis by application, end user, and region
- Discussion of the major market dynamics, key shifts and regulations, industry specific challenges, and macroeconomic factors affecting the demand for CRISPR technology market over the coming years (2022-2027)
- Identification of the companies that are best positioned to meet this demand because of their proprietary technologies, strategic alliances, or other advantages
- A look at the recent technical breakthrough on the use of CRISPR-Cas9 genome editing technology, and how it has propelled the rapid growth in genetic engineering and advanced pharmacological research
- Comparative study on CRISPR with TALE and ZFN nuclease as a gene editing tool and discussion on its higher adaptability over other nucleases
- Review of the patent filings and research publications for innovations in the CRISPR-Cas9 genome editing technology
- Insight into recent industry structure for CRISPR-Cas9 genome editing technology, competitive environment, clinical trials, ongoing research activities, and the COVID-19 impact on the marketplace
- Company profiles of major players within the industry, including CRISPR Therapeutics AG, GenScript, Lonza Group Ltd, PerkinElmer and Thermo Fisher Scientific Inc.
Executive Summary
Summary:
The global market for CRISPR technology is estimated at $REDACTED in 2022 and is expected to increase rapidly by REDACTED% CAGR (compound annual growth rate) to reach $REDACTED in 2027. This report segments the global market by application, end user, and region.
Reasons for Doing This Study:
CRISPR offers lucrative potential for advanced pharmacological research, with impact spanning the entire preclinical drug discovery pipeline. This technology makes gene editing more tractable and precise and speeds up the process of identifying drug targets and generating realistic disease models. High costs associated with the innovation of new drugs are a risk for pharmaceutical companies and may limit the discovery of new therapeutics. New and advanced technologies like CRISPR remove these barriers, expanding the drug exploration process.
This report examines end users, applications, and markets in an effort to help companies and investors prioritize product opportunities and strategic movements. The report highlights key industry and market trends and quantifies the main market segments, allowing the reader to better understand the industry's structure and the changes occurring within it.
Favorable government regulations and funding that supports the application of CRISPR in various scientific fields across all regions create unique market opportunities. This report analyzes the trends and the impact on future growth and developmental opportunities of CRISPR applications in science.
Table of Contents
Chapter 1 Introduction
1.1 Study Goals and Objectives
1.2 Reasons for Doing This Study
1.3 Intended Audience
1.4 Scope of Report
1.5 What's New in this Report?
1.6 Information Sources
1.7 Methodology
1.8 Geographic Breakdown
1.9 Analyst's Credentials
1.10 BCC Custom Research
1.11 Related BCC Research Reports
Chapter 2 Summary and Highlights
2.1 Highlights of the Market for CRISPR Technology
Chapter 3 Market Overview
3.1 CRISPR: Genetic Editing
3.2 Components of CRISPR-Cas Systems
3.2.1 SgRNA
3.2.2 Cas9 Nucleases
3.3 How CRISPR-Cas Works?
3.4 Advantage of the CRISPR-Cas9 System
3.5 Popularity of CRISPR Genome Editing
3.6 Pros of Genetic Editing
3.7 CRISPR Development Phases
3.7.1 Discovery of CRISPR
3.7.2 Discovery of Cas9 and PAM
3.7.3 Hypothesis: Adaptive Immunity
3.7.4 Adaptive Immunity
3.7.5 Spacer Sequences: gRNAs
3.7.6 CRISPR Acts on DNA Targets
3.7.7 Cas9 Cleaves Target DNA
3.7.8 tracrRNA for Cas9 Systems
3.7.9 CRISPR Systems in Other Species
3.7.10 Cas9-Mediated Cleavage
3.7.11 CRISPR-Cas9: Genome Editing
3.8 Market Potential
3.9 Regulatory Framework
3.9.1 U.S. Regulation and Oversight
3.9.2 NIH Guidelines
3.9.3 U.S. FDA
3.9.4 Regulatory Issues
3.9.5 Regulations of Human Germline Edits
3.9.6 Global Regulations
3.10 Porter's Five Forces Analysis of the Market for CRISPR Technology
3.10.1 Bargaining Power of Suppliers: Low
3.10.2 Bargaining Power of Buyers: Moderate
3.10.3 The Threat of Substitutes: Moderate
3.10.4 The Threat of New Entrants: Moderate
3.10.5 The Intensity of Competitive Rivalry: Low
3.11 Scientific Publications
3.12 Patent Analysis
3.12.1 Overview of CRISPR Technology Intellectual Property (IP) and Licensing Structure
3.13 Future of CRISPR
3.14 Market Drivers
3.14.1 CRISPR Versus Chronic Disease
3.14.2 High Prevalence of Genetic Disorders
3.14.3 Government and Private Funding
3.14.4 Increasing Applications of CRISPR
3.15 Market Restraints
3.15.1 Alternative Technologies
3.15.2 Off-target Activity
3.16 Market Challenges
3.16.1 Patent Issues
3.16.2 Risks Associated with CRISPR
3.16.3 R&D
3.16.4 Governmental Policies and Regulations
3.16.5 Bioethical Issues
Chapter 4 Industry Structure
4.1 Commercial Therapeutics
4.2 Correcting Genetic Errors
4.3 Microbes
4.4 Healthier Food
Chapter 5 Impact of COVID-19 on the Market for CRISPR Technology
5.1 Overview
Chapter 6 Competitive Landscape
6.1 Overview
6.2 Competitive Scenario
6.3 Beam Therapeutics
6.4 CRISPR Therapeutics
6.5 Editas Medicine
6.6 Intellia Therapeutics
6.7 Growth Strategies
6.7.1 Licensing and Agreements
6.7.2 Collaborations With Big Biopharmaceutical Companies
6.7.3 Mergers and Acquisitions
Chapter 7 Global Market for CRISPR Technology by End User
7.1 Market Overview
7.2 Market Share and Forecast
7.3 Biotechnology and Pharmaceutical Companies
7.4 Academics and Government Research Institutes
7.5 Contract Research Organizations
Chapter 8 Global Market for CRISPR Technology by Application
8.1 Market Share and Forecast
8.2 Drug Development
8.3 Agriculture
8.4 Diagnostics
8.4.1 Infectious Diseases
8.4.2 Non-infectious diseases
8.5 Clinical Therapy
8.6 Others
Chapter 9 Global Market for CRISPR Technology by Region
9.1 North America
9.1.1 U.S.
9.1.2 Canada
9.2 Europe
9.2.1 Germany
9.2.2 United Kingdom
9.2.3 France
9.2.4 Rest of Europe
9.3 Asia-Pacific
9.3.1 China
9.3.2 Japan
9.3.3 India
9.3.4 Rest of Asia-Pacific
9.4 Rest of the World
Chapter 10 Company Profiles
CARIBOU BIOSCIENCES
CRISPR THERAPEUTICS AG
DANAHER CORP.
EDITAS MEDICINE
GENSCRIPT
HERA BIOLABS
INTELLIA THERAPEUTICS INC.
LONZA GROUP LTD.
MAMMOTH BIOSCIENCES INC.
NEW ENGLAND BIOLABS INC.
ORIGENE TECHNOLOGIES
PERKINELMER
PRECISION BIOSCIENCES
SYNTHEGO
THERMO FISHER SCIENTIFIC
TOOLGEN INC.
List of Tables
Summary Table B : Global Market for CRISPR Technology, by Region, Through 2027
Summary Table A : Global Market for CRISPR Technology, by End User, Through 2027
Table 1 : Comparison of Genome Editing Technologies
Table 2 : Selected Monogenic Disease Details
Table 3 : CRISPR Applications
Table 4 : Global Incidence of Cancer, by Cancer Type/Site, 2020
Table 5 : Venture Capitalist Funding, by Company in Gene Editing
Table 6 : Bioethical Issues and Risks Associated with CRISPR Technology
Table 7 : Selected CAR-T/Gene-Editing Collaborations
Table 8 : CRISPR Technology: Competitive Scenario
Table 9 : CRISPR Technology: Selected Companies
Table 10 : Global Market for CRISPR Technology, by End User, Through 2027
Table 11 : Collaborations among Biotechnology and Pharmaceutical CRISPR Technology Companies
Table 12 : Global Market for CRISPR Technology in Biotechnology and Pharmaceutical End Uses, by Region, Through 2027
Table 13 : Companies Licensing CRISPR Technology from Research Institutions
Table 14 : Global Market for CRISPR Technology in Academic and Government Research Institute End Uses, by Region, Through 2027
Table 15 : Global Market for CRISPR Technology in Contract Research Organization End Uses, by Region, Through 2027
Table 16 : Global Market for CRISPR Technology, by Application, Through 2027
Table 17 : Global Market for Drug Development Applications of CRISPR Technology, by Region, Through 2027
Table 18 : CRISPR: Edited Crops
Table 19 : Global Market for Agriculture-Based Applications of CRISPR Technology, by Region, Through 2027
Table 20 : Global Market for Diagnostic Applications of CRISPR Technology, by Region, Through 2027
Table 21 : Clinical Trial Using CRISPR Technology for Chronic Disease
Table 22 : Global Market for Clinical Therapeutic Applications of CRISPR Technology, by Region, Through 2027
Table 23 : Global Market for Other Applications of CRISPR Technology, by Region, Through 2027
Table 24 : Global Market for CRISPR Technology, by Region, Through 2027
Table 25 : European Market for CRISPR Technology, by Country, Through 2027
Table 26 : Asia-Pacific Market for CRISPR Technology, by Country, Through 2027
Table 27 : Caribou Biosciences: Product Portfolio
Table 28 : Caribou Biosciences: Recent Developments, 2021
Table 29 : CRISPR Therapeutics AG: Product Portfolio
Table 30 : CRISPR Therapeutics AG: Recent Developments, 2021 and 2022
Table 31 : Danaher: Product Portfolio
Table 32 : Danaher: Recent Developments, 2020 and 2021
Table 33 : Editas Medicine: Product Portfolio
Table 34 : Editas Medicine: Recent Developments, 2020-2022
Table 35 : GenScript: Product Portfolio
Table 36 : GenScript: Recent Developments, 2020 and 2021
Table 37 : Hera Biolabs: Product Portfolio
Table 38 : Hera Biolabs: Recent Developments, 2020 and 2021
Table 39 : Intellia Therapeutics Inc.: Product Portfolio
Table 40 : Intellia Therapeutics Inc.: Recent Developments, 2020-2022
Table 41 : Lonza Group Ltd.: Product Portfolio
Table 42 : Lonza Group Ltd.: Recent Developments, 2020 and 2021
Table 43 : Mammoth Biosciences Inc.: Recent Developments, 2020-2022
Table 44 : New England Biolabs Inc.: Product Portfolio
Table 45 : New England Biolabs Inc.: Recent Developments, 2020 and 2021
Table 46 : OriGene Technologies: Product Portfolio
Table 47 : PerkinElmer: Product Portfolio
Table 48 : PerkinElmer: Recent Developments, 2020 and 2021
Table 49 : Precision BioSciences: Product Portfolio
Table 50 : Precision BioSciences: Recent Developments, 2020-2022
Table 51 : Thermo Fisher Scientific Inc.: Product Portfolio
Table 52 : Thermo Fisher Scientific Inc.: Recent Developments, 2020-2022
List of Figures
Summary Figure A : Global Market for CRISPR Technology, by End User, 2019-2027
Summary Figure B : Global Market for CRISPR Technology, by Region, 2019-2027
Figure 1 : CRISPR Timeline, 2016-2021
Figure 2 : Distribution Shares of Scientific Publications on Genome Editing, by Technology, 2018-2021
Figure 3 : Distribution of Scientific Publications on Genome Editing, by Year, 2018-2021
Figure 4 : Published Patents on CRISPR Technology, 2011-2021
Figure 5 : Patent Filings on CRISPR Technology, by Jurisdiction, 2011-2021
Figure 6 : Share of Patent Filings on CRISPR Technology, by Applicant, 2011-2021
Figure 7 : Global Market Shares of CRISPR Technology, by End User, 2021
Figure 8 : Global Market for CRISPR Technology in Biotechnology and Pharmaceutical End Uses, by Region, 2019-2027
Figure 9 : Global Market Shares of CRISPR Technology in Biotechnology and Pharmaceutical End Uses, by Region, 2021
Figure 10 : Global Market for CRISPR Technology in Academic and Government Research Institute End Uses, by Region, 2019-2027
Figure 11 : Global Market Shares of CRISPR Technology in Academic and Government Research Institute End Uses, by Region, 2021
Figure 12 : Global Market for CRISPR Technology in Contract Research Organization End Uses, by Region, 2019-2027
Figure 13 : Global Market Shares of CRISPR Technology in Contract Research Organization End Uses, by Region, 2021
Figure 14 : Global Market Shares of CRISPR Technology, by Application, 2021
Figure 15 : CRISPR Technology in Drug Development
Figure 16 : CRISPR Technology Usage in Drug Development, by Phase (Commercial)
Figure 17 : CRISPR Technology Usage in Drug Development, by Phase (Non-commercial)
Figure 18 : Global Market for Drug Development Applications of CRISPR Technology, by Region, 2019-2027
Figure 19 : Global Market Shares of Drug Development Applications of CRISPR Technology, by Region, 2021
Figure 20 : Global Market for Agriculture-Based Applications of CRISPR Technology, by Region, 2019-2027
Figure 21 : Global Market Shares of Agriculture-Based Applications of CRISPR Technology, by Region, 2021
Figure 22 : Global Market for Diagnostic Applications of CRISPR Technology, by Region, 2019-2027
Figure 23 : Global Market Shares of Diagnostic Applications of CRISPR Technology, by Region, 2021
Figure 24 : Global Market for Clinical Therapeutic Applications of CRISPR Technology, by Region, 2019-2027
Figure 25 : Global Market Shares of Clinical Therapeutic Applications of CRISPR Technology, by Region, 2021
Figure 26 : Global Market for Other Applications of CRISPR Technology, by Region, 2019-2027
Figure 27 : Global Market Shares of Other Applications of CRISPR Technology, by Region, 2021
Figure 28 : Snapshot of the Global Market for CRISPR Technology
Figure 29 : North American Market for CRISPR Technology, 2019-2027
Figure 30 : European Market Shares of CRISPR Technology, by Country, 2021
Figure 31 : German Market for CRISPR Technology, 2019-2027
Figure 32 : U.K. Market for CRISPR Technology, 2019-2027
Figure 33 : French Market for CRISPR Technology, 2019-2027
Figure 34 : Rest of the European Market for CRISPR Technology, 2019-2027
Figure 35 : Asia-Pacific Market Shares of CRISPR Technology, by Country, 2021
Figure 36 : Chinese Market for CRISPR Technology, 2019-2027
Figure 37 : Japanese Market for CRISPR Technology, 2019-2027
Figure 38 : Indian Market for CRISPR Technology, 2019-2027
Figure 39 : Rest of Asia-Pacific Market for CRISPR Technology, 2019-2027
Figure 40 : RoW Market for CRISPR Technology, 2019-2027
Figure 41 : Caribou Biosciences: Annual Revenue, 2019-2021
Figure 42 : CRISPR Therapeutics AG: Annual Revenue, 2019-2021
Figure 43 : Danaher: Annual Revenue, 2019-2021
Figure 44 : Danaher: Market Share, by Region, 2021
Figure 45 : Danaher: Market Share, by Business Segment, 2021
Figure 46 : Editas Medicine: Annual Revenue, 2019-2021
Figure 47 : GenScript: Annual Revenue, 2019-2021
Figure 48 : GenScript: Market Share, by Business Segment, 2021
Figure 49 : GenScript: Market Share, by Region, 2021
Figure 50 : Intellia Therapeutics Inc.: Annual Revenue, 2020 and 2021
Figure 51 : Lonza Group Ltd.: Annual Revenue, 2019-2021
Figure 52 : Lonza Group Ltd.: Market Share, by Region, 2021
Figure 53 : Lonza Group Ltd.: Market Share, by Business Segment, 2021
Figure 54 : PerkinElmer: Discovery and Analytical Solutions, Revenue, 2019-2021
Figure 55 : PerkinElmer: Market Share, by Business Segment, 2021
Figure 56 : PerkinElmer: Market Share, Discovery and Analytical Solutions, by Region, 2021
Figure 57 : Precision BioSciences: Annual Revenue, 2019-2021
Figure 58 : Precision BioSciences: Market Share, by Business Segment, 2021
Figure 59 : Thermo Fisher Scientific Inc.: Annual Revenue, 2019-2021
Figure 60 : Thermo Fisher Scientific Inc.: Market Share, by Region, 2021
Figure 61 : Thermo Fisher Scientific Inc.: Market Share, by Business Segment, 2021
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security